
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
AZD9291 Resistance Reversal Activity of a pH‐Sensitive Nanocarrier Dual‐Loaded with Chloroquine and FGFR1 Inhibitor in NSCLC
Yu Gu, Songtao Lai, Yang Dong, et al.
Advanced Science (2020) Vol. 8, Iss. 2
Open Access | Times Cited: 32
Yu Gu, Songtao Lai, Yang Dong, et al.
Advanced Science (2020) Vol. 8, Iss. 2
Open Access | Times Cited: 32
Showing 1-25 of 32 citing articles:
Exosome-liposome hybrid nanoparticle codelivery of TP and miR497 conspicuously overcomes chemoresistant ovarian cancer
Longxia Li, Di He, Qianqian Guo, et al.
Journal of Nanobiotechnology (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 138
Longxia Li, Di He, Qianqian Guo, et al.
Journal of Nanobiotechnology (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 138
Chemodynamic and Photothermal Combination Therapy Based on Dual-Modified Metal–Organic Framework for Inducing Tumor Ferroptosis/Pyroptosis
Huizi Deng, Jun Zhang, Yifan Yang, et al.
ACS Applied Materials & Interfaces (2022) Vol. 14, Iss. 21, pp. 24089-24101
Closed Access | Times Cited: 105
Huizi Deng, Jun Zhang, Yifan Yang, et al.
ACS Applied Materials & Interfaces (2022) Vol. 14, Iss. 21, pp. 24089-24101
Closed Access | Times Cited: 105
Nano-ultrasonic Contrast Agent for Chemoimmunotherapy of Breast Cancer by Immune Metabolism Reprogramming and Tumor Autophagy
Xupeng Yang, Meng Zhao, Zhihua Wu, et al.
ACS Nano (2022) Vol. 16, Iss. 2, pp. 3417-3431
Closed Access | Times Cited: 78
Xupeng Yang, Meng Zhao, Zhihua Wu, et al.
ACS Nano (2022) Vol. 16, Iss. 2, pp. 3417-3431
Closed Access | Times Cited: 78
Multifunctional nanoparticle for cancer therapy
Yan Gao, Kaiyu Wang, Jin Zhang, et al.
MedComm (2023) Vol. 4, Iss. 1
Open Access | Times Cited: 46
Yan Gao, Kaiyu Wang, Jin Zhang, et al.
MedComm (2023) Vol. 4, Iss. 1
Open Access | Times Cited: 46
Autophagy inhibitors for cancer therapy: Small molecules and nanomedicines
Jianli Chen, Xuan Wu, Dan Yin, et al.
Pharmacology & Therapeutics (2023) Vol. 249, pp. 108485-108485
Open Access | Times Cited: 43
Jianli Chen, Xuan Wu, Dan Yin, et al.
Pharmacology & Therapeutics (2023) Vol. 249, pp. 108485-108485
Open Access | Times Cited: 43
Lysosomal-mediated drug release and activation for cancer therapy and immunotherapy
Yinping Sun, Yongjie Sha, Guanhong Cui, et al.
Advanced Drug Delivery Reviews (2022) Vol. 192, pp. 114624-114624
Closed Access | Times Cited: 43
Yinping Sun, Yongjie Sha, Guanhong Cui, et al.
Advanced Drug Delivery Reviews (2022) Vol. 192, pp. 114624-114624
Closed Access | Times Cited: 43
Nanomedicine Combats Drug Resistance in Lung Cancer
Xiuli Zheng, Xiao-Hai Song, Guonian Zhu, et al.
Advanced Materials (2023) Vol. 36, Iss. 3
Closed Access | Times Cited: 36
Xiuli Zheng, Xiao-Hai Song, Guonian Zhu, et al.
Advanced Materials (2023) Vol. 36, Iss. 3
Closed Access | Times Cited: 36
Multi‐Targeted Peptide‐Modified Gold Nanoclusters for Treating Solid Tumors in the Liver
Feng Xiao, Yao Chen, Jie Qi, et al.
Advanced Materials (2023) Vol. 35, Iss. 20
Closed Access | Times Cited: 34
Feng Xiao, Yao Chen, Jie Qi, et al.
Advanced Materials (2023) Vol. 35, Iss. 20
Closed Access | Times Cited: 34
Emerging Nano-Based Strategies Against Drug Resistance in Tumor Chemotherapy
Lei Cao, Yuqin Zhu, Weiju Wang, et al.
Frontiers in Bioengineering and Biotechnology (2021) Vol. 9
Open Access | Times Cited: 51
Lei Cao, Yuqin Zhu, Weiju Wang, et al.
Frontiers in Bioengineering and Biotechnology (2021) Vol. 9
Open Access | Times Cited: 51
Multi-target tyrosine kinase inhibitor nanoparticle delivery systems for cancer therapy
Wenjing Xu, Chunping Ye, Qing Xin, et al.
Materials Today Bio (2022) Vol. 16, pp. 100358-100358
Open Access | Times Cited: 29
Wenjing Xu, Chunping Ye, Qing Xin, et al.
Materials Today Bio (2022) Vol. 16, pp. 100358-100358
Open Access | Times Cited: 29
An elastase-inhibiting, plaque-targeting and neutrophil-hitchhiking liposome against atherosclerosis
Shi Yin, Mei Dong, Yue Wu, et al.
Acta Biomaterialia (2023) Vol. 173, pp. 470-481
Closed Access | Times Cited: 18
Shi Yin, Mei Dong, Yue Wu, et al.
Acta Biomaterialia (2023) Vol. 173, pp. 470-481
Closed Access | Times Cited: 18
Systemic administration of polymersomal oncolytic peptide LTX-315 combining with CpG adjuvant and anti-PD-1 antibody boosts immunotherapy of melanoma
Yifeng Xia, Jingjing Wei, Songsong Zhao, et al.
Journal of Controlled Release (2021) Vol. 336, pp. 262-273
Closed Access | Times Cited: 36
Yifeng Xia, Jingjing Wei, Songsong Zhao, et al.
Journal of Controlled Release (2021) Vol. 336, pp. 262-273
Closed Access | Times Cited: 36
Nanomedicines for Overcoming Cancer Drug Resistance
Tingting Hu, Hanlin Gong, Jiayue Xu, et al.
Pharmaceutics (2022) Vol. 14, Iss. 8, pp. 1606-1606
Open Access | Times Cited: 28
Tingting Hu, Hanlin Gong, Jiayue Xu, et al.
Pharmaceutics (2022) Vol. 14, Iss. 8, pp. 1606-1606
Open Access | Times Cited: 28
Mesoporous manganese nanocarrier target delivery metformin for the co-activation STING pathway to overcome immunotherapy resistance
Yuanyao Dou, Jie Zheng, Jun Kang, et al.
iScience (2024) Vol. 27, Iss. 7, pp. 110150-110150
Open Access | Times Cited: 5
Yuanyao Dou, Jie Zheng, Jun Kang, et al.
iScience (2024) Vol. 27, Iss. 7, pp. 110150-110150
Open Access | Times Cited: 5
Nanomedicines for combating multidrug resistance of cancer
Ya‐Xuan Zhu, Hao‐Ran Jia, Qiu‐Yi Duan, et al.
Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology (2021) Vol. 13, Iss. 5
Closed Access | Times Cited: 29
Ya‐Xuan Zhu, Hao‐Ran Jia, Qiu‐Yi Duan, et al.
Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology (2021) Vol. 13, Iss. 5
Closed Access | Times Cited: 29
An orthogonally activatable CRISPR-Cas13d nanoprodrug to reverse chemoresistance for enhanced chemo-photodynamic therapy
Zheng Liu, Zhiyuan Feng, Mohan Chen, et al.
Chemical Science (2023) Vol. 14, Iss. 15, pp. 4102-4113
Open Access | Times Cited: 12
Zheng Liu, Zhiyuan Feng, Mohan Chen, et al.
Chemical Science (2023) Vol. 14, Iss. 15, pp. 4102-4113
Open Access | Times Cited: 12
Targeted co-delivery of methotrexate and chloroquine via a pH/enzyme-responsive biocompatible polymeric nanohydrogel for colorectal cancer treatment
Hamid Rashidzadeh, Ali Ramazani, Seyed Jamal Tabatabaei Rezaei, et al.
Journal of Biomaterials Science Polymer Edition (2023) Vol. 34, Iss. 13, pp. 1824-1842
Open Access | Times Cited: 11
Hamid Rashidzadeh, Ali Ramazani, Seyed Jamal Tabatabaei Rezaei, et al.
Journal of Biomaterials Science Polymer Edition (2023) Vol. 34, Iss. 13, pp. 1824-1842
Open Access | Times Cited: 11
Chitosan-based bone-targeted nanoparticles delivery of cyclolinopeptide J for the synergistic treatment of osteoporosis
Jiazi Chen, Wen Li, Jianhao Zhao, et al.
International Journal of Biological Macromolecules (2025) Vol. 304, pp. 140884-140884
Closed Access
Jiazi Chen, Wen Li, Jianhao Zhao, et al.
International Journal of Biological Macromolecules (2025) Vol. 304, pp. 140884-140884
Closed Access
Multieffect Specific Nanovesicles for Homing Resistant Tumors and Overcoming Osimertinib‐Acquired Resistance in NSCLC
Yuanyao Dou, Yihui Liu, Rui Han, et al.
Advanced Healthcare Materials (2025)
Closed Access
Yuanyao Dou, Yihui Liu, Rui Han, et al.
Advanced Healthcare Materials (2025)
Closed Access
Nanomedicine Approaches for Autophagy Modulation in Cancer Therapy
Sohaib Mahri, Raffaella Villa, Ya‐Ping Shiau, et al.
Small Science (2025)
Open Access
Sohaib Mahri, Raffaella Villa, Ya‐Ping Shiau, et al.
Small Science (2025)
Open Access
Nanotechnology in cancer treatment: revolutionizing strategies against drug resistance
Syed Mubashar Sabir, Ali Salman B. Thani, Qamar Abbas
Frontiers in Bioengineering and Biotechnology (2025) Vol. 13
Open Access
Syed Mubashar Sabir, Ali Salman B. Thani, Qamar Abbas
Frontiers in Bioengineering and Biotechnology (2025) Vol. 13
Open Access
Integrin-targeting disulfide-crosslinked micellar docetaxel eradicates lung and prostate cancer patient-derived xenografts
Dawei Ni, Beibei Guo, Z Zhong, et al.
Acta Biomaterialia (2023) Vol. 170, pp. 228-239
Open Access | Times Cited: 9
Dawei Ni, Beibei Guo, Z Zhong, et al.
Acta Biomaterialia (2023) Vol. 170, pp. 228-239
Open Access | Times Cited: 9
Enhanced Sensitivity of Tumor Cells to Autophagy Inhibitors Using Fasting-Mimicking Diet and Targeted Lysosomal Delivery Nanoplatform
Ruihao Qian, Guoliang Cao, Wen Su, et al.
Nano Letters (2022) Vol. 22, Iss. 22, pp. 9154-9162
Closed Access | Times Cited: 13
Ruihao Qian, Guoliang Cao, Wen Su, et al.
Nano Letters (2022) Vol. 22, Iss. 22, pp. 9154-9162
Closed Access | Times Cited: 13
Precise Targeting Therapy of Orthotopic Gastric Carcinoma by siRNA and Chemotherapeutic Drug Codelivered in pH‐Sensitive Nano Platform
Quan Wang, Yu Tian, Lei Liu, et al.
Advanced Healthcare Materials (2021) Vol. 10, Iss. 20
Closed Access | Times Cited: 16
Quan Wang, Yu Tian, Lei Liu, et al.
Advanced Healthcare Materials (2021) Vol. 10, Iss. 20
Closed Access | Times Cited: 16